Medtronic announces the launch of their Next-Gen Bluetooth automated insulin delivery (AID) and CGM systems!

At last year’s Advanced Technologies and Treatment for Diabetes (ATTD) Conference in Berlin, Germany, Medtronic announced that they will be launching their Next-Gen of AID and CGM systems while sharing the results of a recent study they conducted on children who use their 670G AID system.

The study conducted evaluated the efficiency of the 670G AID (automated insulin delivery) system in children from 2-6 years old. The results were positive. After 3 months, the participants:

• Reduced their A1c’s by 0.5% (from a baseline of 8.0%)
• Increased their “time in range” by 2 hours per day
• Had no change in time spent in less than 70 mg/dl
• No experiences of severe hypoglycemia or DKA 

This is exciting news for this age group of 2-6-year-old children and their caretakers as it provides a safe and convenient way of managing diabetes in young kids.

Next-Gen AIDs & CGMs

In addition to this great news for younger kids and their families, Medtronic shared several products that they plan to launch over the next several years, phased into “1 year” and “2+ year” timelines.

These products hope to offer a wide range of new features, including:

• An 85% or greater time-in-range and an average glucose of less than 130 mg/dl from their personalized closed loops
• 50% smaller CGM sensors & pumps at a lower cost
• Smartphone app
• All-in-one CGM sensor and insulin infusion set
• Infusion sets with up to seven days of wear

This is such positive information in the on-going advances of CGM and automated insulin delivery systems for children and adults with type 1 diabetes.

Click here for in-depth details of these advances.

Written by Catherine Cullinane RN, CDCES, our resident Tech Thursday Content Writer

---

Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE!  Sign up below!

[yikes-mailchimp form=”1″]